SOX9 and cystic fibrosis: In vitro, we show that, following Sox9 or Aspn knockdown, miR–129-5p inhibitor is no longer able to significantly promote expression of MF and OF markers in CF, suggesting that SOX9 and ASPN are indeed essential for miR–129-5p–dependent CF activity.